Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: The Takahata study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Otaki, Yoichiro ^a   Watanabe, Tetsu ^a   Takahashi, Hiroki ^a   Hirayama, Atushi ^a   Narumi, Taro ^a   Kadowaki, Shinpei ^a   Honda, Yuki ^a   Arimoto, Takanori ^a   Shishido, Tetsuro ^a   Miyamoto, Takuya ^a   Konta, Tsuneo ^a   Shibata, Yoko ^a   Fukao, Akira ^a   Daimon, Makoto ^b   Ueno, Yoshiyuki ^a   Kato, Takeo ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; BRAIN NATRIURETIC PEPTIDE; FABP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PROTEIN BLOOD LEVEL; SURVIVOR; BLOOD; CARDIOVASCULAR DISEASE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; ROC CURVE;

EID: 84901353638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094834     Document Type: Article

References (46)

1. Chen J, Normand SL, Wang Y, Krumholz HM (2011) National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA 306: 1669-1678.
2. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, et al. (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106: 3068-3072. (Pubitemid 35440290)
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112: 154-235.
4. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, et al. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96: 509-516. (Pubitemid 27329427)
5. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Rosjo H, et al. (2013) Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 61: 1240-1249.
6. Braga JR, Tu JV, Austin PC, Chong A, You JJ, et al. (2013) Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation. Circ Heart Fail 6: 193-202.
7. Ahmad T, Fiuzat M, Felker GM, O'Connor C (2012) Novel biomarkers in chronic heart failure. Nat Rev Cardiol 9: 347-359.
8. Eggers KM, Venge P, Lindahl B, Lind L (2013) Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol 61: 1906-1913.
9. Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, et al. (2012) Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention. Clin Chem 58: 200-208.
10. Glatz JF, Paulussen RJ, Veerkamp JH (1985) Fatty acid binding proteins from heart. Chem Phys Lipids 38: 115-129. (Pubitemid 15226751)
11. Daidoji H, Arimoto T, Nitobe J, Tamura H, Kutsuzawa D, et al. (2012) Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators. J Card Fail 18: 556-563.
12. Matsumoto S, Nakatani D, Sakata Y, Suna S, Shimizu M, et al. (2013) Elevated Serum Heart-Type Fatty Acid-Binding Protein in the Convalescent Stage Predicts Long-Term Outcome in Patients Surviving Acute Myocardial Infarction. Circ J. 77: 1026-1032.
13. Arimoto T, Takeishi Y, Shiga R, Fukui A, Tachibana H, et al. (2005) Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 11: 56-60. (Pubitemid 40215315)
14. Examination Committee of Criteria for 'Obesity' in Japan; Japan Society for the Study of Obesity (2002) New criteria for 'obesity disease' in Japan. Circ J 66: 987-992.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
17. Eckardt KU, Berns JS, Rocco MV, Kasiske BL (2009) Definition and classification of CKD: the debate should be about patient prognosis - a position statement from KDOQI and KDIGO. Am J Kidney Dis 53: 915-920.
18. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: 1-266.
19. Arimoto T, Takeishi Y, Niizeki T, Nozaki N, Hirono O, et al. (2007) Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. J Card Fail 13: 34-41. (Pubitemid 46330832)
20. Niizeki T, Takeishi Y, Arimoto T, Takahashi T, Okuyama H, et al. (2005) Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ J 69: 922-927. (Pubitemid 41124259)
21. Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, et al. (2007) Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 13: 120-127. (Pubitemid 46467389)
22. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
24. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, et al. (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304: 2503-2512.
25. deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, et al. (2010) Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 304: 2494-2502.
26. Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, et al. (2010) Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 55: 2590-2598.
27. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, et al. (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92: 715-724. (Pubitemid 36457635)
28. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, et al. (1997) Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141.
29. Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, et al. (2008) Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 29: 2252-2258.
30. Meng X, Ming M, Wang E (2006) Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. Forensic Sci Int 160: 11-16. (Pubitemid 43928397)
31. Mann J, Davies MJ (1999) Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 82: 265-268. (Pubitemid 29429594)
32. Mervaala E, Muller DN, Park JK, Dechend R, Schmidt F, et al. (2000) Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. Hypertension 35: 360-366. (Pubitemid 30054200)
33. Hernandez AF, Mi X, Hammill BG, Hammill SC, Heidenreich PA, et al. (2012) Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction. JAMA 308: 2097-2107.
34. Chiu YT, Chen YT, Lin NN, Cheng CC, Gong CL, et al. (2005) Sympathetic activity and myocardial damage after stimulation of dorsal medulla and vagotomy in a novel animal model. Int J Cardiol 100: 401-407.
35. Narumi T, Shishido T, Kiribayashi N, Kadowaki S, Nishiyama S, et al. (2012) Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study. Exp Diabetes Res 2012: 815098.
36. Niizeki T, Takeishi Y, Takabatake N, Shibata Y, Konta T, et al. (2007) Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics. Circ J 71: 1452-1457. (Pubitemid 47378449)
37. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, et al. (2011) Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123: 1367-1376.
38. Sakata Y, Shimokawa H (2013) Epidemiology of heart failure in Asia. Circ J 77: 2209-2217.
39. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578. (Pubitemid 351232031)
40. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638. (Pubitemid 36459468)
41. Stengel B (2010) Chronic kidney disease and cancer: a troubling connection. J Nephrol 23: 253-262.
42. George AJ, Thomas WG, Hannan RD (2010) The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10: 745-759.
43. Jee SH, Kim HJ, Lee J (2005) Obesity, insulin resistance and cancer risk. Yonsei Med J 46: 449-455. (Pubitemid 41283053)
44. de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, et al. (2012) Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. Am Heart J 163: 821-828.
45. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H (2011) Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan - first report from the CHART-2 study. Circ J 75: 823-833.
46. NIPPON DATA80 Research Group (2006) Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 70: 1249-1255.